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Abstract 1 The internal face of the detrusor smooth muscle wall of the urinary bladder is covered by a 2 mucosa, separating muscle from the hostile environment of urine.   However, the mucosa is 3 more than a very low permeability structure and offers a sensory structure that monitors the 4 extent of bladder filling and composition of the urine.  The mucosa may be considered as a 5 single functional structure and comprises a tight epithelial layer under which is a basement 6 membrane and lamina propria.  The latter region itself is a complex of afferent nerves, blood 7 vessels, interstitial cells and in some species including humans a muscularis mucosae.  Stress 8 on the bladder wall through physical or chemical stressors elicits release of chemicals, such 9 as ATP, acetylcholine, prostaglandins and nitric oxide, that modulate the activity of either 10 afferent nerves or the muscular components of the bladder wall.  The release and responses 11 are graded so that the mucosa forms a dynamic sensory structure and there is evidence that 12 the gain of this system is increased in pathologies such as overactive bladder and bladder pain 13 syndrome.  This system therefore potentially provides a number of drug targets against these 14 conditions, once a number of fundamental questions are answered.  These include: how is 15 mediator release regulated; what are the intermediate roles of interstitial cells that surround 16 afferent nerves and blood vessels as; what is the mode of communication between urothelium 17 and muscle – by diffusion of mediators or by cell-to-cell communication?  18   19 
 3 
Introduction 1 The urinary bladder has two functions: to store urine, up to 500 ml in the normal adult, and 2 to completely void its content when expeditious.  Storage is associated with very little increase 3 of intravesical pressure and low bladder wall tension; whilst voiding occurs with a sustained 4 rise of pressure, sufficient to overcome outflow resistance, due to contraction of detrusor 5 smooth muscle.  This two-state system is controlled by the central nervous system but 6 modulated by interaction between different cell types in the layers of the bladder wall.  In 7 pathological conditions such as overactive bladder this on-off process may be disrupted by 8 uncontrolled activity that could elicit unpleasant sensations of urinary urgency or pain and 9 also contractions that may be powerful enough to cause involuntary loss of urine.  It is 10 therefore important to understand how storage and voiding modalities of the bladder are 11 controlled to provide therapies that minimize these pathologies. 12  13 
Structure of the bladder wall 14 The smooth muscle (detrusor) of the bladder wall is protected by an external serosa and on 15 the vesical face overlain by a mucosa that itself consists of a tight transitional epithelium 16 (urothelium), basement membrane and lamina propria (LP; Figure 1).  The urothelium itself 17 is covered by a mucopolysaccharide glycocalyx that offers protection for the urothelium from 18 the hostile medium of urine.  The urothelium is made up of three layers: a basal cell layer 19 attached to a basement membrane, an intermediate layer and a superficial or apical layer 20 composed of large hexagonal cells known as the “umbrella cells”.  An essential function of the 21 urothelium is to offer an effective barrier between urine and underlying tissues, achieved by 22 tight junctions between umbrella cells, severely limiting solute and water movement across 23 the barrier [1,2].  Damage to the urothelium, evident on exposure to noxious agents or 24 associated with pathologies such as spinal cord injury [3], are accompanied by irritative lower 25 urinary tract symptoms.  However, the urothelium has transport functions as evidenced by 26 the development of a finite membrane potential, solute and water movement and the presence 27 of aquaporins, urea transporters, ion channels (eg ENaC) and mineralocorticoid receptors [4-28 6].  Moreover, the different composition of urine sampled from the bladder lumen and renal 29 pelvis is consistent with post-renal urinary tract salt and water exchange [7].  30  31 The LP that separates the urothelium from the detrusor layer is composed of an extracellular 32 matrix containing interstitial cells, fibroblasts, adipocytes, afferent and efferent nerve 33 
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endings, blood vessels and, in some species including humans, a more ill-defined muscular 1 layer – the muscularis mucosae.  The functional interaction of these different cells and how 2 they communicate with the urothelium and detrusor layers is crucial to understand how this 3 layer has essential roles to sense bladder filling as well as exert control over detrusor 4 contractile activity.   5  6 The detrusor layer itself constitutes the mass of the bladder wall and consists of smooth 7 muscle bundles separated by connective tissue and interstitial cells.  Parasympathetic 8 postganglionic nerves provide the excitatory input. 9 
 10 
The release of mediators and sensations arising from the bladder wall 11 Physical or chemical stressors applied to the bladder itself, isolated sections of the bladder 12 wall, strips of mucosa dissected free of detrusor, or isolated urothelial cells evoke release of 13 several small molecules including: ATP, acetylcholine (ACh), prostaglandins or nitric oxide 14 [4,8-10].  The fact that all these preparations release these compounds assumes that the 15 source is the urothelium, although the contribution from other cells has not been 16 systematically evaluated. Physical stressors include longitudinal strain or tension; the rate of 17 change of these variables; transmural pressure changes; osmotic swelling; or shear stresses 18 to cells; chemical or cellular stressors include extracellular acidosis [11], noxious compounds 19 such as doxorubicin [12] and inflammatory conditions [13].  Primary sensory neurons also 20 release several neuropeptides such as CGRP and substance-P that may mediate local 21 inflammatory responses [14].  However, this is beyond the scope of this article and will not be 22 considered further.  23  24 The pathways for release and their signaling roles have been mostly investigated for ATP and 25 ACh.  Overall, their action will be largely autocrine or paracrine as extracellular ATPases 26 (eNTPDases) and cholinesterases will limit their half-time.  In principle, these mediators can 27 either affect local afferent nerves to convey sensations of filling to the central nervous system, 28 regulate local blood flow by affecting vessel resistance, or modulate detrusor contractile 29 function.  Mucosa afferents express a number of receptors that include: P2X and P2Y 30 purinergic families; TRP –V, -M, and –A families; as well as PAC1 (pituitary adenylate cyclase-31 activating polypeptide (PACAP))-selective receptors.  P2X2/3 receptors are understood to 32 mediate the excitatory effects of locally released ATP.  P2X3 knock-out mice showed a 33 
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diminished micturition reflex whereby greater stretch of the bladder wall was required to 1 elicit a given degree of afferent signaling.  However, activity was not abolished [15] 2 completely, which may suggest additional roles for CGRP, TRPV1 and PACAP receptors [15,16] 3 although their functional ligands are yet to be fully elucidated.  The lifetime and extent of the 4 effect for ATP released from the urothelium will be limited due to the presence of ectoATPases 5 (E-NTPDase3) on the basal surfaces of urothelial cells [17].  This would be anticipated for a 6 dynamic sensory modulator but also raises the question of the roles of ADP, AMP and 7 adenosine in also modulating signalling responses. 8  9 The quantity of ATP released during imposition of stressors alters with the age and the 10 pathology of the parent tissue, suggesting an underlying cause of pathological lower urinary 11 tract sensations.  Thus, ATP release is raised in bladder wall tissue from: old animals and 12 humans compared to younger counterparts [18], tissue biopsies of patients with overactive 13 bladders [19] and cultured urothelial cells of patients with painful bladder syndrome/ 14 interstitial cystitis [20].   15  16 Urothelial cells also have the capacity to synthesise and exhibit stretch-activated release of 17 acetylcholine (ACh) [21,22].  There is inconsistent evidence as to whether release is enhanced 18 [22] or diminished [18] with age, but several other agents including the cytotoxic drug, 19 doxorubicin, and lipopolysaccharide reduced ACh release stimulated by cell stretch [23,24].  20 Comparison of ACh and ATP release reveals some interesting differences: stretch-activated 21 release of ACh is much greater than ATP per unit mass of tissue; the magnitude of stresses 22 required to release ACh is much smaller, as is the dynamic range of stresses that release ACh 23 [25].  Moreover, the release of ATP is modulated by muscarinic receptor activation 24 independently of physical stressors; muscarinic receptor agonists increase ATP release whilst 25 antagonists, particularly to M2 but not M3 receptors, inhibit it.  Thus, it has been suggested 26 that ACh release is the first step in a sensory transducer system that itself regulates the further 27 release of ATP with consequent downstream effects [25,26]. Two observations follow which 28 question perceived wisdom about the use of antimuscarinic agents to manage overactive 29 bladder (OAB) symptoms: firstly their site of action may not solely be on detrusor M3 30 receptors at the efferent nerve/smooth muscle junction, as assumed, but also on the mucosa; 31 secondly drugs with a mixed M2/M3 profile may be more effective then selective M3 receptor 32 antagonists.  Certainly, antimuscarinic agents increase cystometric capacity in patients with 33 
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OAB, which can be explained by their action on storage rather than solely on voiding 1 mechanisms. 2 Stretch-induced prostaglandin (PGE2) from the mucosa has also been measured and may 3 exert direct effects on detrusor contractile function or, via an EP1 receptor, enhance local ATP 4 release to increase afferent activation [27].  Moreover, a positive feedback process is 5 suggested by the ability of ATP to augment PGE2 release [28].  Urothelial cells contain the 6 enzymatic machinery to synthesise nitric oxide (NO) [29] and there is evidence that it 7 suppresses afferent nerve activity [30].  Increase of NO production, as occurs for example in a 8 cat model of bladder pain syndrome, is also associated with a loss of barrier function [31] that 9 in turn will augment afferent activity by allowing noxious components of urine more direct 10 access to suburothelial structures. 11 
 12 
Pathways for mediator release 13 Significant effort has been expended to identify the cellular routes for mediator release and 14 suggests the involvement of several pathways. ATP release has been identified via hemi-15 channels of connexin or pannexin proteins, or even through vesicles [32,33].  However, these 16 conclusions are generally based on inhibitors of hemichannel proteins or vesicular transport 17 and there is debate about the specificity of these agents.  In addition, release is enhanced by 18 an increase of intracellular [Ca2+] that may underlie the augmentation of release by TRPV1 19 channel activation and extracellular acidosis [11] and is attenuated by extracellular Ca2+ that 20 is consistent with involvement of connexin hemichannels.  However, the mode of action of P2Y 21 receptor agonists that increase release and adenosine (A1) receptor agonists that reduce 22 release has not been clarified.  Of interest is that ATP release is reduced from the tissue of 23 patients who have received botulinum toxin type-A (BnTx-A) injections to reduce overactive 24 bladder symptoms [34].  Moreover, direct application of BnTx-A attenuates stress-dependent 25 ATP release and the binding targets for BnTx-A has been identified on urothelial cells [35].  26 This also raises the question whether BnTx-A as an agent to reduce OAB contractions, does so 27 by reducing transmitter release from efferent nerves, as it has assumed to work, or by 28 dampening the sensory responses to bladder filling, as suggested by these observations.  29 Release of ACh is via different routes: it is unaffected by reduction of vesicular formation, 30 blockade of hemichannels or botulinum toxin.  The only effective modulator identified was an 31 inhibitor of CFTR channels, which reduced release by about 50% [25]. 32 
 33 
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The mucosa and contractile functions of the bladder 1 Contractile function in the bladder exists in two modalities: phasic contractions initiated by 2 transmitters released from efferent parasympathetic fibres that evoke large contractions to 3 void urine; spontaneous contractions that are not primarily initiated by motor nerves.  The 4 origin and function of the latter remain unclear but they have several properties that 5 distinguish them from nerve-mediated contractions and imply they have a physiological and 6 pathological role:  7 
• they are unaffected by neurotoxins, but are Ca2+-sensitive;  8 
• they are greatly augmented by the mucosa overlaying the detrusor;  9 
• they can manifest as micromotions – localised, non-propagating contractions on the 10 bladder wall – that are mirrored as small intravesical   pressure fluctuations;  11 
• they are enhanced in pathologies that manifest as overactive bladders. 12 Their normal function may be to maintain a significant tone in the bladder wall during filling 13 to ensure it maintains a roughly spherical shape but not enough to reduce the natural 14 compliance of the bladder in this phase.  Several, not mutually exclusive, theories have been 15 proposed that might also contribute to the large spontaneous contractions associated with a 16 subtype of OAB called detrusor overactivity: 17 
• a myogenic theory, due to intrinsic spontaneous activity of detrusor myocytes 18 
• a neurogenic hypothesis whereby spontaneous nervous activity initiated in the central or 19 peripheral nervous system drives contractions. 20 
• spontaneous release of neurotransmitters 21 
• a urotheliogenic theory whereby the mucosa drives spontaneous detrusor contractions. 22 
• the mucosa itself has significant, independent contractile function 23 Of these the urotheliogenic theory and an independently contractile mucosa are the most 24 consistent with experimental evidence, although a neurogenic origin is likely in a subset of 25 patients.  However, the questions arise about the nature of the interaction between mucosa 26 and detrusor, as well as how the mucosa itself generates significant contractile activity. 27 
 28 
 29 
The contractile properties of the mucosa 30 The mucosa, in most species, may be readily separated from the detrusor layer by blunt 31 dissection and in vitro generates spontaneous contractions, as well as tonic responses to 32 electrical field stimulation and cholinergic agonists [36-38].  Several origins, not mutually 33 
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exclusive, have been proposed including: interstitial cells with a contractile phenotype 1 (myofibroblasts); pericytes around blood vessels or the muscularis mucosae.  It is evident that 2 the pharmacological profile of mucosa spontaneous contractions is different from that of the 3 detrusor layer, for example capsaicin augments detrusor activity whilst suppressing mucosal 4 activity [37].  This would argue against the possibility that in dissecting the preparations there 5 is residual contamination of detrusor smooth muscle.  This phenomenon is of significance as 6 the mucosa thickens in several conditions associated with overactive bladder [39] and this 7 activity may be especially significant in these pathologies.  There is also evidence that such 8 contractility activity may be influenced by mucosal ATP release.  Under resting conditions 9 mucosal ATP release is cyclical with a periodicity of about 10 minutes and this is reflected in 10 a similar periodicity of the integral of spontaneous contractility but with a delay of a few 11 minutes [37].  It might be suggested that ATP release form urothelium diffuses within the 12 mucosa to modulate contractility activity.  It does not identify the cellular targets except that 13 they probably have a receptor phenotype to ATP or its metabolites.  The contractile behavior 14 of the mucosal layer under various pathological conditions has not yet been investigated: 15 however, there is a change in the characteristics of spontaneous contractions of this layer with 16 ageing [40].  17  18 
Functional interactions between the mucosa, detrusor and associated vasculature 19 There is also convincing evidence of mucosa-detrusor interaction in generating spontaneous 20 activity – the urotheliogenic theory.  The most straightforward observation is that an in vitro 21 bladder wall preparation of detrusor and attached mucosa generates substantial spontaneous 22 contractions and these are dramatically reduced when the mucosa is removed [41,42].  This 23 is complicated by the fact that an intact mucosa overlaying detrusor muscle also exerts a tonic 24 negative inotropic effect [43].  This complex interaction can be by diffusion of mediators 25 between the two layers or from a cellular interaction.  The observation that simply placing a 26 mucosa layer over previously denuded detrusor restores some contractile activity supports a 27 role for a diffusive interaction.  However, if this was the sole mode of interaction it would be 28 expected that the pharmacological profile of spontaneous contractions would be solely 29 determined by the phenotype of detrusor and this is not the case.  Apart from the opposite 30 actions of capsaicin on mucosa and detrusor activity (above), the same is true of P2Y receptor 31 agonists such as ADP, UDP and UDP.  These agonists generally suppress or are at least neutral 32 on detrusor function but they increase mucosa activity [37].  Moreover they greatly enhance 33 
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spontaneous contractions of bladder wall preparations when mucosa and detrusor or 1 attached [44].  Optical imaging experiments that map intracellular [Ca2+] and membrane 2 potential propagated waves across the bladder wall reveal not only is an intact mucosa 3 required for such activity but it is augmented by the above P2Y agonists.  Moreover, these 4 experiments also show that such propagated activity is initiated in the sub-urothelium of the 5 mucosa and actually propagates to the detrusor – again augmented by P2Y agonists [44].  6 These mapping experiments also suggest that local diffusion of agents is insufficient alone to 7 explain mucosa-detrusor interaction as the propagation velocity of such waves is too rapid 8 and moreover too extensive over the bladder wall and suggests cellular interaction is also 9 likely. 10  11 One potential cellular mediator of mucosa-detrusor interaction is the dense network of 12 interstitial cells in the suburothelium – a network substantially increased in pathologies 13 associated with enhanced spontaneous activity such as spinal cord injury [38].  These cells 14 tend to have their cell bodies in the suburothelium nearest to the urothelium, but projections 15 run towards the detrusor layer where much of the immunoreactivity to the gap junction 16 protein connexin-43 is found.  These cells also have the attributes of forming an electrical 17 functional syncytium: they are connected by connexin-43 gap junctions; and also generate 18 spontaneous depolarisations due to activation of a large density Ca2+ activated Cl- current, ICl,Ca 19 [44].  Moreover, ICl,Ca is enhanced by interventions that accelerate Ca2+ wave propagation both 20 across the bladder wall and between mucosa and detrusor, namely P2Y agonists and local 21 reduction of pH.  It may be proposed therefore that a function of suburothelial interstitial cells 22 is to provide a cellular communication between the mucosa and detrusor that will augment 23 contractile activity of the latter.  The cells are ideally located below the urothelium to respond 24 to mediators released from this layer, as well as their metabolites and their excitable nature 25 means they can effectively propagate responses. 26  27 Moreover, interstitial cells might be involved in the local control of bladder tissue perfusion 28 as a subpopulation of these cells is associated with the microvessels in the LP [45]. It is 29 postulated that adjacent perivascular interstitial cells have a role in generating spontaneous 30 vasoconstrictions of venules, which might be beneficial in maintaining blood flow during the 31 filling phase of the micturition cycle [46]. Inadequate perfusion of the bladder and the 32 resultant ischemia can readily affect the urothelium and suburothelial cells, leading to altered 33 
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urothelial signaling/barrier function and detrusor smooth muscle overactivity [47]. The 1 relationship between suburothelial microvessels, interstitial cells and the urothelium needs 2 to be further studied.  3  4 
Conclusions. 5 The mucosa lining the inner surface of the detrusor smooth muscle layer of the bladder has 6 essential roles other than providing an essential barrier function to protect detrusor from the 7 unphysiological environment of urine.  The urothelium acts as a sensor to bladder filling, 8 although it has to be determined what is the actual physical stressor: wall stress, transmural 9 pressure, acidosis from ischaemia, etc.  The urothelium responds by releasing chemical 10 mediators that eventually activate afferent nerves and/or locally influence muscle function.  11 The role of intermediate cells, such as interstitial cells, remains to be determined. However, 12 their electrically excitable nature gives them the capacity to modulate the function of nerves, 13 detrusor muscle and even local blood vessels.  Overall, the mucosa offers a dynamic sensory 14 structure that allows the bladder to respond directly to the volume and composition of urine 15 and thus optimise bladder contractile function.  A major unanswered question is whether 16 pathological changes to bladder function, such as overactive bladder and bladder pain 17 syndrome, are determined by alterations to mucosa behaviour. 18 
 19 20 
 11 
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 1 Figure 1.  Section of the sheep bladder wall.  The section shows the urothelium, sub-2 urothelium and detrusor smooth muscle layers.  The suburothelium is a complex structure of 3 blood vessels, interstitial cells, afferent nerves and in this species a muscularis mucosae (m.m.).  4 External physical and chemical agents can cause release of mediators (arrows) from the 5 urothelium that could influence suburothelium structures to elicit nervous responses, 6 changes to blood vessel tone and contractile responses of detrusor and possibly muscularis 7 
mucosae.  Contractile responses could be mediated either by diffusion of mediators and/or by 8 cell-to-cell communication. 9 
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